Cambiar Investors LLC Laboratory Corp Of America Holdings Transaction History

Cambiar Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$209.01 - $232.56 $253,320 - $281,862	1,212 Added 0.5%	241,749 $52.8 Million
Q4 2023 Jan 25, 2024	SELL	$197.69 - $227.29 $180,095 - $207,061	-911 Reduced 0.38%	240,537 $54.7 Million
Q3 2023 Oct 30, 2023	BUY	$201.05 - $221.7 $6.16 Million - $6.8 Million	30,661 Added 14.55%	241,448 $48.5 Million
Q2 2023 Jul 31, 2023	BUY	$211.93 - $241.33 $1.18 Million - $1.35 Million	5,586 Added 2.72%	210,787 $50.9 Million
Q1 2023 May 08, 2023	SELL	$213.32 - $257.83 $767,738 - $927,930	-3,599 Reduced 1.72%	205,201 $47.1 Million
Q4 2022 Feb 02, 2023	BUY	$203.72 - $248.97 $42.5 Million - $52 Million	208,800 New	208,800 $49.1 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Cambiar Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Cambiar Investors LLC with notifications on news.